Cargando…
Corrigendum to “Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus” [Heliyon 9(4) (April 2023) e15032]
Autores principales: | Hernandez, Nancy E., Jankowski, Wojciech, Frick, Rahel, Kelow, Simon P., Lubin, Joseph H., Simhadri, Vijaya, Adolf-Bryfogle, Jared, Khare, Sagar D., Dunbrack, Roland L., Gray, Jeffrey J., Sauna, Zuben E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493423/ https://www.ncbi.nlm.nih.gov/pubmed/37701412 http://dx.doi.org/10.1016/j.heliyon.2023.e17901 |
Ejemplares similares
-
Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus
por: Hernandez, Nancy E., et al.
Publicado: (2023) -
RosettaAntibodyDesign (RAbD): A general framework for computational antibody design
por: Adolf-Bryfogle, Jared, et al.
Publicado: (2018) -
Hiding in plain sight: structure and sequence analysis reveals the importance of the antibody DE loop for antibody-antigen binding
por: Kelow, Simon P., et al.
Publicado: (2020) -
Modeling Immunity with Rosetta: Methods for Antibody
and Antigen Design
por: Schoeder, Clara T., et al.
Publicado: (2021) -
A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection
por: McGill, Joseph R., et al.
Publicado: (2022)